NO167026C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivaterInfo
- Publication number
- NO167026C NO167026C NO863608A NO863608A NO167026C NO 167026 C NO167026 C NO 167026C NO 863608 A NO863608 A NO 863608A NO 863608 A NO863608 A NO 863608A NO 167026 C NO167026 C NO 167026C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- benzimidazold
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8513453A FR2587029B1 (fr) | 1985-09-11 | 1985-09-11 | Derives de benzimidazole, leur preparation et leur application en therapeutique |
Publications (4)
Publication Number | Publication Date |
---|---|
NO863608D0 NO863608D0 (no) | 1986-09-10 |
NO863608L NO863608L (no) | 1987-03-12 |
NO167026B NO167026B (no) | 1991-06-17 |
NO167026C true NO167026C (no) | 1991-09-25 |
Family
ID=9322797
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO863608A NO167026C (no) | 1985-09-11 | 1986-09-10 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater |
NO2001017C NO2001017I1 (no) | 1985-09-11 | 2001-10-15 | Mizolastine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2001017C NO2001017I1 (no) | 1985-09-11 | 2001-10-15 | Mizolastine |
Country Status (25)
Country | Link |
---|---|
US (2) | US4820710A (xx) |
EP (1) | EP0217700B1 (xx) |
JP (1) | JPS6261979A (xx) |
KR (1) | KR930001411B1 (xx) |
AR (1) | AR243187A1 (xx) |
AT (1) | ATE103603T1 (xx) |
AU (1) | AU582894B2 (xx) |
CA (1) | CA1272486A (xx) |
CS (1) | CS357991A3 (xx) |
DE (2) | DE3689748T2 (xx) |
DK (1) | DK170594B1 (xx) |
ES (1) | ES2001782A6 (xx) |
FI (1) | FI87210C (xx) |
FR (1) | FR2587029B1 (xx) |
GR (1) | GR862318B (xx) |
HK (1) | HK1005592A1 (xx) |
HU (1) | HU196597B (xx) |
IE (1) | IE61607B1 (xx) |
IL (1) | IL79992A (xx) |
LU (1) | LU90085I2 (xx) |
NL (1) | NL970029I2 (xx) |
NO (2) | NO167026C (xx) |
NZ (1) | NZ217537A (xx) |
PT (1) | PT83355B (xx) |
ZA (1) | ZA866901B (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2618435B1 (fr) * | 1987-07-23 | 1989-10-27 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
FR2637595B1 (fr) * | 1988-10-11 | 1990-11-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
JPH02294758A (ja) * | 1989-05-09 | 1990-12-05 | Nec Corp | 計算機使用時間管理方式 |
FR2658823B1 (fr) * | 1990-02-27 | 1992-04-30 | Adir | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . |
FR2666582B1 (fr) * | 1990-09-07 | 1994-09-02 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique. |
FR2693194B1 (fr) * | 1992-07-03 | 1994-09-23 | Synthelabo | Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique. |
FR2745500B1 (fr) * | 1996-03-04 | 1998-04-03 | Synthelabo | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
JPH10101564A (ja) * | 1996-09-27 | 1998-04-21 | Mitsubishi Chem Corp | 鼻炎予防及び/又は治療剤 |
US6369235B1 (en) | 1997-02-25 | 2002-04-09 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection |
FR2762214B1 (fr) * | 1997-04-17 | 2000-10-06 | Synthelabo | Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation |
EP0958820A1 (en) * | 1998-05-19 | 1999-11-24 | Sanofi-Synthelabo | Use of an imidazol derivative for the manufacture of a medicament for treating auto-immunodiseases |
ES2208098B1 (es) * | 2002-10-02 | 2005-10-16 | Ragactives, S.L. | Procedimiento e intermedios para la obtencion de derivados de 1-(1h-bencimidazol-2-il)-4-(2-aminopirimidin) piperidina. |
AR045955A1 (es) * | 2003-09-30 | 2005-11-16 | Janssen Pharmaceutica Nv | Compuestos benzoimidazolicos |
ES2245227B1 (es) * | 2004-04-06 | 2007-03-01 | Ragactives, S.L. | Formas cristalinas de mizolastina, procedimientos para su obtencion y composiciones farmaceuticas que las contienen. |
AU2010266040B2 (en) * | 2009-06-25 | 2015-01-15 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds |
EP2445502B2 (en) | 2009-06-25 | 2022-09-28 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
CN102140076A (zh) * | 2010-02-03 | 2011-08-03 | 辽宁本源制药有限公司 | 咪唑斯汀中间体的制备 |
ES2715562T3 (es) | 2011-12-15 | 2019-06-04 | Alkermes Pharma Ireland Ltd | Profármacos de compuestos de amina secundaria |
CN112423754A (zh) | 2018-03-05 | 2021-02-26 | 奥克梅斯制药爱尔兰有限公司 | 阿立哌唑的给药策略 |
KR20210136106A (ko) * | 2019-04-11 | 2021-11-16 | 데이진 화-마 가부시키가이샤 | 벤즈이미다졸 유도체 및 이들의 용도 |
US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281005A (en) * | 1979-03-05 | 1981-07-28 | Merck & Co., Inc. | Novel 2-pyridylimidazole compounds |
US4556660A (en) * | 1982-07-12 | 1985-12-03 | Janssen Pharmaceutica N.V. | N-(Bicyclic heterocyclyl)-4-piperidinamines |
DE3484096D1 (de) * | 1983-11-30 | 1991-03-14 | Janssen Pharmaceutica Nv | Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine. |
US4588722A (en) * | 1984-01-09 | 1986-05-13 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
-
1985
- 1985-09-11 FR FR8513453A patent/FR2587029B1/fr not_active Expired
-
1986
- 1986-09-02 DE DE3689748T patent/DE3689748T2/de not_active Expired - Lifetime
- 1986-09-02 EP EP86401928A patent/EP0217700B1/fr not_active Expired - Lifetime
- 1986-09-02 DE DE1997175081 patent/DE19775081I2/de active Active
- 1986-09-02 AT AT86401928T patent/ATE103603T1/de active
- 1986-09-09 IL IL79992A patent/IL79992A/xx not_active IP Right Cessation
- 1986-09-10 AU AU62552/86A patent/AU582894B2/en not_active Expired
- 1986-09-10 IE IE241686A patent/IE61607B1/en not_active IP Right Cessation
- 1986-09-10 HU HU863907A patent/HU196597B/hu unknown
- 1986-09-10 ZA ZA866901A patent/ZA866901B/xx unknown
- 1986-09-10 DK DK431586A patent/DK170594B1/da not_active IP Right Cessation
- 1986-09-10 KR KR1019860007594A patent/KR930001411B1/ko not_active IP Right Cessation
- 1986-09-10 GR GR862318A patent/GR862318B/el unknown
- 1986-09-10 AR AR86305197A patent/AR243187A1/es active
- 1986-09-10 FI FI863661A patent/FI87210C/fi not_active IP Right Cessation
- 1986-09-10 JP JP61214978A patent/JPS6261979A/ja active Granted
- 1986-09-10 PT PT83355A patent/PT83355B/pt unknown
- 1986-09-10 NO NO863608A patent/NO167026C/no not_active IP Right Cessation
- 1986-09-10 CA CA000517916A patent/CA1272486A/en not_active Expired - Lifetime
- 1986-09-10 US US06/906,279 patent/US4820710A/en not_active Expired - Lifetime
- 1986-09-10 ES ES8601773A patent/ES2001782A6/es not_active Expired
- 1986-09-10 NZ NZ217537A patent/NZ217537A/xx unknown
-
1988
- 1988-12-12 US US07/283,468 patent/US4912219A/en not_active Expired - Lifetime
-
1991
- 1991-11-25 CS CS913579A patent/CS357991A3/cs unknown
-
1997
- 1997-07-25 NL NL970029C patent/NL970029I2/nl unknown
- 1997-07-30 LU LU90085C patent/LU90085I2/fr unknown
-
1998
- 1998-06-02 HK HK98104746A patent/HK1005592A1/xx not_active IP Right Cessation
-
2001
- 2001-10-15 NO NO2001017C patent/NO2001017I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO169493C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater | |
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO172343C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater | |
NO171638C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater | |
NO864425L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater | |
NO843979L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater | |
NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO169014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater | |
NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
NO170482C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO169648C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |